Epilepsy Awareness Month: Shining a Light on a Hidden Condition
Epilepsy, a neurological disorder characterized by recurring seizures, affects over 3 million people in the United States. In honor of Epilepsy Awareness Month, organizations are working to raise awareness and dispel common misconceptions about the condition.
New Medications Offer Hope for Epilepsy Management
The FDA has approved two new medications for the treatment of epilepsy:
Valtoco
Valtoco is a once-daily medication for adults and children with focal onset seizures, the most common type of epilepsy. In clinical trials, Valtoco significantly reduced seizure frequency compared to placebo.
Epidyolex
Epidyolex is a cannabidiol-based medication for children and young adults with two rare forms of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. Epidyolex has shown promise in reducing the severity and frequency of seizures in these conditions.
Caregiver Support: Essential for Epilepsy Management
Caregivers of individuals with epilepsy play a vital role in their overall well-being.
Conclusion
Epilepsy Awareness Month serves as a reminder of the importance of understanding and supporting those who live with epilepsy. The development of new medications and the recognition of the invaluable role of caregivers offer hope and improved outcomes for those affected by this condition.
Kind regards
E. Thompson
